Albion Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
1,246
+104
+9% +$106K 0.09% 92
2026
Q1
$1.05M Buy
1,142
+25
+2% +$25.3K 0.07% 102
2025
Q4
$1.2M Sell
1,117
-60
-5% -$57.4K 0.07% 99
2025
Q3
$898K Buy
1,177
+9
+0.8% +$6.7K 0.05% 113
2025
Q2
$910K Buy
1,168
+15
+1% +$11.7K 0.06% 114
2025
Q1
$952K Hold
1,153
0.07% 118
2024
Q4
$890K Buy
1,153
+27
+2% +$22.4K 0.06% 122
2024
Q3
$998K Hold
1,126
0.07% 114
2024
Q2
$1.02M Hold
1,126
0.08% 108
2024
Q1
$876K Sell
1,126
-6
-0.5% -$4.27K 0.07% 115
2023
Q4
$660K Sell
1,132
-3
-0.3% -$1.75K 0.05% 127
2023
Q3
$610K Buy
1,135
+9
+0.8% +$4.64K 0.06% 122
2023
Q2
$528K Buy
1,126
+102
+10% +$42.8K 0.05% 132
2023
Q1
$352K Sell
1,024
-15
-1% -$5.06K 0.03% 147
2022
Q4
$380K Sell
1,039
-10
-1% -$3.55K 0.04% 142
2022
Q3
$339K Hold
1,049
0.04% 142
2022
Q2
$340K Hold
1,049
0.03% 150
2022
Q1
$300K Sell
1,049
-24
-2% -$6.18K 0.03% 179
2021
Q4
$296K Buy
1,073
+48
+5% +$12.2K 0.02% 189
2021
Q3
$237K Hold
1,025
0.02% 172
2021
Q2
$235K Buy
+1,025
New +$206K 0.02% 176
2020
Q4
$173K Buy
+1,025
New +$153K 0.02% 188

Other funds holding LLY

Albion Financial Group's LLY Position: Q2 2026 in Review

Albion Financial Group increased its Eli Lilly (LLY) stake by 9.1% in Q2 2026, buying an estimated $106K and bringing the position to 1,246 shares worth $1.49M. The position accounts for 0.09% of the portfolio, ranked #92.

Albion Financial Group first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Albion Financial Group held 1,246 shares of Eli Lilly worth $1.49M as of Q2 2026.
  • Albion Financial Group bought 104 Eli Lilly shares in Q2 2026, an estimated $106K.
  • Eli Lilly made up 0.09% of Albion Financial Group's portfolio in Q2 2026, its #92 holding.
  • Albion Financial Group first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.